tirzepatide isn't working GLP-1 drugs such as semaglutide and are transforming obesity and diabetes care in India, but experts warn that improper use could lead to significant muscle loss. A new India-specific consensus highlights The RISKS & BENEFITS of

In the Phase 3 ATTAIN-1 trial, adults with obesity taking the highest approved dose achieved an average weight loss of 12.4% at 72 weeks compared with approximately 0.9% with placebo

Before you begin taking semaglutide, talk to your doctor about your medical history, especially if youve ever had pancreatitis or gallbladder issues

Jpn Heart J 1996;37:177- 182

Plans, patients, and pharmacies have significant risk with these drugs included on every PBM formulary in the country

Political turmoil This leads to a perfect storm

Do not store semaglutide directly against the back wall where cooling elements might cause localized freezing